Rare deal of a Chinese drug firm buying an Indian company likely this week Hong Kong-listed Shanghai Fosun Pharmaceutical (Group) has agreed to buy Hyderabad-based Gland Pharma, backed by private......
FIPB on Monday cleared Rs 6,400-crore (Rs 64-billion) foreign direct investment proposal of GlaxoSmithKline to acquire additional 24.33 per cent stake in its India arm. "The proposal of......
It's the hope rally that pushed frontline stocks to higher levels on Thursday. Markets remained exuberant after a gap-up opening but came off its peak as the day progressed as investors booked......
Foreign direct investment in the pharma sector has more than doubled to $1.07 billion during April-August period amid concerns over increasing acquisitions of domestic firms by multinationals. FDI......
The finance ministry on Friday said it has approved 15 foreign investment proposals totalling Rs 2,000.5 crore (Rs 20 billion) and recommended two FDI applications, including that of US drug major......